KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Astrana Health (ASTH) Return on Sales: 2009-2025

Historic Return on Sales for Astrana Health (ASTH) over the last 17 years, with Q3 2025 value amounting to 0.0%.

  • Astrana Health's Return on Sales fell 400.0% to 0.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.02% for FY2024, which is 100.0% down from last year.
  • Astrana Health's Return on Sales amounted to 0.0% in Q3 2025, which was down 400.0% from 0.02% recorded in Q2 2025.
  • Over the past 5 years, Astrana Health's Return on Sales peaked at 0.32% during Q2 2021, and registered a low of 0.09% during Q4 2021.
  • Over the past 5 years, Astrana Health's median Return on Sales value was 0.04% (recorded in 2024), while the average stood at 0.04%.
  • The largest annual percentage gain for Astrana Health's Return on Sales in the last 5 years was 1000bps (2022), contrasted with its biggest fall of -2800bps (2022).
  • Quarter analysis of 5 years shows Astrana Health's Return on Sales stood at 0.09% in 2021, then soared by 97bps to 0.0% in 2022, then plummeted by -1083bps to 0.04% in 2023, then surged by 49bps to 0.02% in 2024, then soared by 106bps to 0.0% in 2025.
  • Its Return on Sales was 0.0% in Q3 2025, compared to 0.02% in Q2 2025 and 0.01% in Q1 2025.